Rochester General Hospital is a clinical research site located in Rochester, New York, United States 14621.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Rochester General Hospital has participated in 115 clinical trials with 39 currently active.
Therapeutic areas: Heart Failure With Preserved Ejection Fraction (HFpEF, Recurrent Small Cell Lung Carcinoma, Degenerative Mitral Valve Disease.
Sponsors: Axon Therapies, Inc., Roswell Park Cancer Institute, Edwards Lifesciences.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Rochester
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rochester General Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rochester General Hospital has 115 clinical trials on record, with 39 currently active. Their work covers Heart Failure With Preserved Ejection Fraction (HFpEF, Recurrent Small Cell Lung Carcinoma, Degenerative Mitral Valve Disease.
Rochester General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.